Treace Medical Concepts, Inc.(TMCI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TMCI Treace Medical Concepts, Inc.

Trading 04-07 15:46:37 EDT

7.61

-0.14

-1.81%

High8.13	Low7.13	Vol311.94K
Open7.35	D1 Closing7.75	Amplitude12.87%
Mkt Cap476.35M	Tradable Cap361.16M	Total Shares62.60M
T/O2.34M	T/O Rate0.66%	Tradable Shares47.46M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"TMCI","market":"US","secType":"STK","nameCN":"Treace Medical Concepts, Inc.","latestPrice":7.61,"timestamp":1744055192470,"preClose":7.75,"halted":0,"volume":311935,"delay":0,"floatShares":47458924,"shares":62595334,"eps":-0.899999,"marketStatus":"Trading","change":-0.14,"latestTime":"04-07 15:46:37 EDT","open":7.35,"high":8.1299,"low":7.1326,"amount":2338530.341459,"amplitude":0.128684,"askPrice":7.62,"askSize":125,"bidPrice":7.59,"bidSize":366,"shortable":3,"etf":0,"ttmEps":-0.899999,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1744056000000},"marketStatusCode":2,"adr":0,"listingDate":1619150400000,"exchange":"NASDAQ","adjPreClose":7.75,"preHourTrading":{"tag":"盘前","latestPrice":6.95,"preClose":7.75,"latestTime":"08:03 EDT","volume":105,"amount":732.050004,"timestamp":1744027383274},"postHourTrading":{"tag":"盘后","latestPrice":7.75,"preClose":7.75,"latestTime":"16:49 EDT","volume":359819,"amount":2788597.4,"timestamp":1743799746678},"volumeRatio":0.740067,"impliedVol":2.2166,"impliedVolPercentile":0.9641},"requestUrl":"/m/hq/s/TMCI/wiki","defaultTab":"wiki","newsList":[{"id":"2525004810","title":"BRIEF-Treace Announces Upcoming Board Chair Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2525004810","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525004810?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 20:48","pubTimestamp":1744030088,"startTime":"0","endTime":"0","summary":"BRIEF-Treace Announces Upcoming Board Chair TransitionApril 7 (Reuters) - Treace Medical Concepts Inc TMCI.O:TREACE ANNOUNCES UPCOMING BOARD CHAIR TRANSITIONTREACE MEDICAL CONCEPTS INC - APPOINTS JOHN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUAMY0X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMCI","BK4539","BK4082"],"gpt_icon":0},{"id":"2525102920","title":"Treace Medical Concepts Names John Treace as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2525102920","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525102920?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 20:30","pubTimestamp":1744029053,"startTime":"0","endTime":"0","summary":"Treace Medical Concepts  said Monday its board appointed founder and CEO John Treace as chairman, effective after the company's annual stockholders meeting on May 20.John Treace succeeds James Treace, who is retiring from the board on the same date, the medical technology company said.John Treace will retain his role as CEO, according to the company.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","TMCI","BK4539"],"gpt_icon":0},{"id":"2525801205","title":"Treace Medical Concepts Inc - Appoints John T. Treace as Chairman of the Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2525801205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525801205?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 20:00","pubTimestamp":1744027202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUAMY0X2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMCI","BK4539","BK4082"],"gpt_icon":0},{"id":"2525120810","title":"Treace Announces Upcoming Board Chair Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2525120810","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525120810?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 20:00","pubTimestamp":1744027202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUAMY0X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMCI","BK4539","BK4082"],"gpt_icon":0},{"id":"2525038012","title":"Treace Medical Concepts Inc - James T. Treace to Retire From Board on May 20, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525038012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525038012?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 20:00","pubTimestamp":1744027202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUAMY0X2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4539","TMCI"],"gpt_icon":0},{"id":"2525301277","title":"Press Release: Treace Announces Upcoming Board Chair Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2525301277","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525301277?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"PONTE VEDRA, Fla., April 07, 2025  -- Treace Medical Concepts, Inc.  , a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty and Adductoplasty Procedures, today announced that its Board of Directors has appointed John. T. Treace, Chief Executive Officer and Founder of Treace, as the Chairman of the Board to be effective immediately following the 2025 annual meeting of stockholders. Mr. John. T. Treace will succeed James T. Treace, who notified the Board that he will retire from the Board when his current term as a director ends at the 2025 Annual Meeting of Stockholders, which is expected to occur on May 20, 2025. John T. Treace will continue to serve as Chief Executive Officer and will assume the role of Chairman of the Board immediately following the 2025 Annual Meeting of Stockholders. Richard W. Mott will continue to serve as the lead independent director.\"I am honored to be appo","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMCI","R","BK4585","BK4232","BK4539","BK4099","BK4588","BK4082","BK4604","TM","BK4022","BK4555","03160"],"gpt_icon":0},{"id":"2523682144","title":"Treace Medical Concepts Studies of Procedures to Treat Mid-Foot Deformities Show Positive Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2523682144","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523682144?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 03:23","pubTimestamp":1743189791,"startTime":"0","endTime":"0","summary":"Treace Medical Concepts  said Friday its interim data from clinical trials of lapiplasty and adductoplasty to treat bunions and related mid-foot deformities showed low recurrence and continued improvement in pain.Clinical study data of the two studies of lapiplasty procedure showed a return to protected weight bearing at an average of 7.9 and 8.4 days with recorded pain improvement at 12 months and 48 months.Data from the study of adductoplasty procedure showed return to protected weight bearing at an average of 7.5 days with recorded pain improvement at 12 months.The company presented the interim data at the 2025 American College of Foot and Ankle Surgeons Annual Meeting in Phoenix, Arizona.Price: 8.50, Change: +0.13, Percent Change: +1.55","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TMCI","BK4539","BK4082"],"gpt_icon":0},{"id":"2523896176","title":"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 Acfas Annual Scientific Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2523896176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523896176?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 02:00","pubTimestamp":1743184800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA2FJTGY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4539","TMCI"],"gpt_icon":0},{"id":"2523899956","title":"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2523899956","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523899956?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 02:00","pubTimestamp":1743184800,"startTime":"0","endTime":"0","summary":"“We are excited to feature our growing body of clinical data to surgeons attending the 2025 ACFAS conference,” stated John T. Treace, CEO, Founder and Board Member of Treace. “This builds on our commitment to support our flagship Lapiplasty and Adductoplasty procedures with clinical evidence and notably marks the first meeting where all three of our prospective, multicenter studies are presented, including our ALIGN3D, Mini3D, and MTA3D studies, demonstrating positive clinical outcomes and further differentiating these procedures with surgeons and patients.”ALIGN3D clinical study results presented by Daniel Hatch, DPM  on Friday, March 28 as a podium presentation entitled, “Four-Year Analysis of a Five-Year Prospective Multicenter Study Assessing Radiographic Recurrence and Patient Outcomes Following Triplanar Tarsometatarsal Arthrodesis with Early Weightbearing.” The featured interim data from the prospective, five-year, multicenter ALIGN3D clinical study of the Lapiplasty Procedure i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/treace-announces-clinical-study-data-180000203.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TMCI"],"gpt_icon":0},{"id":"2522156880","title":"Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2522156880","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522156880?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:15","pubTimestamp":1742933700,"startTime":"0","endTime":"0","summary":"Expands market-leading position with new best-in-class bunion technologies. PONTE VEDRA, Fla., March 25, 2025  -- Treace Medical Concepts, Inc.  , a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty and Adductoplasty Procedures, today announced new technology innovations featured at the 2025 American College of Foot and Ankle Surgeons  Annual Scientific Conference in Phoenix, Arizona from March 27-30, 2025.“We are excited to have another strong presence at ACFAS, highlighting our commitment to surgical podiatry and advancing our company’s focused mission to improve surgical outcomes for bunion patients.” said John T. Treace, CEO, Founder and Board Member of Treace. “We will showcase several new innovations in our expanding and comprehensive bunion portfolio and also look forward to sharing compelling clinical evidence on our flagship Lapiplasty and Adductoplasty procedures during p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/treace-highlights-innovations-2025-acfas-201500526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TMCI","BK4539","BK4082"],"gpt_icon":0},{"id":"2519685361","title":"Treace Medical Concepts Is Maintained at Hold by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2519685361","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519685361?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 22:55","pubTimestamp":1741877700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMCI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2025 10:55 ET (14:55 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMCI","BK4082","BK4539"],"gpt_icon":0},{"id":"2519833584","title":"Truist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2519833584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519833584?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:37","pubTimestamp":1741865835,"startTime":"0","endTime":"0","summary":"In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Treace Medical Concepts (TMCI – Research Report), wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-hold-rating-for-treace-medical-concepts-tmci-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-hold-rating-for-treace-medical-concepts-tmci-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMCI"],"gpt_icon":0},{"id":"2519885558","title":"Truist Adjusts Price Target on Treace Medical Concepts to $9.50 From $10, Maintains Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2519885558","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519885558?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 17:41","pubTimestamp":1741858883,"startTime":"0","endTime":"0","summary":"Treace Medical Concepts (TMCI) has an average rating of overweight and mean price target of $11.29, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TMCI"],"gpt_icon":0},{"id":"2518285640","title":"John Treace Spends US$524k On Treace Medical Concepts Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2518285640","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518285640?lang=en_us&edition=full_marsco","pubTime":"2025-03-09 21:42","pubTimestamp":1741527724,"startTime":"0","endTime":"0","summary":"Those following along with Treace Medical Concepts, Inc.  will no doubt be intrigued by the recent purchase of shares by John Treace, CEO, Founder & Director of the company, who spent a stonking US$524k on stock at an average price of US$8.73. There's no denying a buy of that magnitude suggests conviction in a brighter future, although we do note that proportionally it only increased their holding by 0.5%.Check out our latest analysis for Treace Medical Concepts. The Last 12 Months Of Insider Transactions At Treace Medical Concepts. Notably, that recent purchase by CEO, Founder & Director John Treace was not the only time they bought Treace Medical Concepts shares this year. Earlier in the year, they paid US$4.58 per share in a US$1.4m purchase. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$8.57. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us muc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/john-treace-spends-us-524k-134204934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","TMCI","BK4082"],"gpt_icon":0},{"id":"2517635937","title":"CEO Makes Bold Move with Major Stock Purchase in Treace Medical Concepts","url":"https://stock-news.laohu8.com/highlight/detail?id=2517635937","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517635937?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 10:01","pubTimestamp":1741140103,"startTime":"0","endTime":"0","summary":"New insider activity at Treace Medical Concepts ( ($TMCI) ) has taken place on March 5, 2025. CEO John T. Treace has made a significant investment ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/ceo-makes-bold-move-with-major-stock-purchase-in-treace-medical-concepts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/ceo-makes-bold-move-with-major-stock-purchase-in-treace-medical-concepts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMCI","BK4539","BK4082"],"gpt_icon":0},{"id":"1195894772","title":"Stock Track | Treace Medical Concepts Plummets 5.21% as Analysts Maintain Neutral Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1195894772","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195894772?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 04:10","pubTimestamp":1741032629,"startTime":"0","endTime":"0","summary":"Treace Medical Concepts, Inc.  saw its stock plummet 5.21% in the intraday trading session on Monday. The decline came as analysts from major financial institutions maintained their neutral ratings and price targets for the company.Truist Securities reiterated its \"Hold\" rating on TMCI, while UBS adjusted its price target to $10 from $7.90 but kept a \"Neutral\" rating. According to analysts polled by FactSet, TMCI has an average rating of \"Overweight\" and a mean price target of $11.36.The stock's","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Treace Medical Concepts Plummets 5.21% as Analysts Maintain Neutral Ratings","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TMCI"],"gpt_icon":0},{"id":"2516653292","title":"Treace Medical Concepts Is Maintained at Hold by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2516653292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516653292?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 00:23","pubTimestamp":1741018980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMCI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2025 11:23 ET (16:23 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TMCI","BK4539"],"gpt_icon":0},{"id":"2516919653","title":"UBS Adjusts Treace Medical Concepts Price Target to $10 From $7.90, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516919653","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516919653?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 00:19","pubTimestamp":1741018789,"startTime":"0","endTime":"0","summary":"Treace Medical Concepts (TMCI) has an average rating of overweight and mean price target of $11.36, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TMCI"],"gpt_icon":0},{"id":"2516680028","title":"Truist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516680028","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516680028?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 20:28","pubTimestamp":1741004880,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Richard Newitter maintained a Hold rating on Treace Medical Concepts (TMCI – Research Report) today and set a price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-hold-rating-for-treace-medical-concepts-tmci?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-hold-rating-for-treace-medical-concepts-tmci?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMCI"],"gpt_icon":0},{"id":"2516687723","title":"Treace Medical Concepts Inc : Truist Securities Raises Target Price to $10 From $8.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2516687723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516687723?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 20:06","pubTimestamp":1741003597,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM0S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMCI","BK4539","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.treace.com","stockEarnings":[{"period":"1week","weight":-0.0828},{"period":"1month","weight":-0.1512},{"period":"3month","weight":-0.019},{"period":"6month","weight":0.4513},{"period":"1year","weight":-0.3471},{"period":"ytd","weight":0.0417}],"compareEarnings":[{"period":"1week","weight":-0.0907},{"period":"1month","weight":-0.1334},{"period":"3month","weight":-0.1464},{"period":"6month","weight":-0.1182},{"period":"1year","weight":-0.0152},{"period":"ytd","weight":-0.1379}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.096397},{"month":2,"riseRate":0.25,"avgChangeRate":0.000856},{"month":3,"riseRate":0.25,"avgChangeRate":-0.009706},{"month":4,"riseRate":0.25,"avgChangeRate":-0.068236},{"month":5,"riseRate":0.5,"avgChangeRate":-0.115133},{"month":6,"riseRate":0.25,"avgChangeRate":-0.021217},{"month":7,"riseRate":0.5,"avgChangeRate":0.031519},{"month":8,"riseRate":0.25,"avgChangeRate":-0.111513},{"month":9,"riseRate":0.5,"avgChangeRate":-0.012422},{"month":10,"riseRate":0.25,"avgChangeRate":-0.11626},{"month":11,"riseRate":0.25,"avgChangeRate":0.099506},{"month":12,"riseRate":0.5,"avgChangeRate":0.09966}],"exchange":"NASDAQ","name":"Treace Medical Concepts, Inc.","nameEN":"Treace Medical Concepts, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Treace Medical Concepts, Inc.(TMCI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Treace Medical Concepts, Inc.(TMCI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Treace Medical Concepts, Inc.,TMCI,Treace Medical Concepts, Inc.股票,Treace Medical Concepts, Inc.股票老虎,Treace Medical Concepts, Inc.股票老虎国际,Treace Medical Concepts, Inc.行情,Treace Medical Concepts, Inc.股票行情,Treace Medical Concepts, Inc.股价,Treace Medical Concepts, Inc.股市,Treace Medical Concepts, Inc.股票价格,Treace Medical Concepts, Inc.股票交易,Treace Medical Concepts, Inc.股票购买,Treace Medical Concepts, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Treace Medical Concepts, Inc.(TMCI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Treace Medical Concepts, Inc.(TMCI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}